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SUMMARY
Objective: This study provides a description and analysis of characteristics of the monitoring system for congenital anomalies at birth and 
prevalence trends in Latvia using retrospective analysis of congenital anomalies at birth with cross-sectional data on prevalence (national data 
from Latvia, 2000–2010). 
Methods: There are three main monitoring systems on congenital anomalies among newborns and infants: the Medical Birth Register with data 
on live births with one or more congenital anomalies at birth, the Register on Congenital Anomalies with genetically approved cases for live births 
and the National Causes of Death Register with data on stillbirths. Methodological problems were analysed by calculating different prevalence 
rates. The main outcome measures are as follows: prevalence rate, live birth prevalence rate, major congenital anomalies live birth prevalence 
rate, and stillbirth rate. 
Results: The live birth period prevalence was 319.7/10,000 live births, and the major congenital anomalies live birth prevalence was 211.4/10,000. 
The period total prevalence rate of births was 323.7/10,000 live births and stillbirths. The stillbirth rate due to congenital anomalies was 6.1/10,000 
live and stillbirths. The live birth prevalence with congenital anomalies decreased slightly from the year 2000 to the year 2010. 
Conclusions: The present system of congenital anomaly registration requires improvements for better completeness. Latvia should use the 
experience of Nordic countries and introduce a mother’s and children’s identification number to the Medical Birth Register. It would be helpful to 
link the information from hospitals and perinatal centres together to validate the congenital anomaly diagnoses of newborns after their discharge 
from the maternity unit. The monitoring system should also include information on pregnancies with congenital anomalies which do not end in 
birth, especially terminations of pregnancy.
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INTRODUCTION
Public health policies have recognised the necessity to improve 
the health of mothers and infants as one of the important tasks at 
both national and international levels worldwide. One of the tasks 
of the public health system is to collect data that can be used for 
monitoring birth defects, performing genetic and epidemiologi-
cal studies as well as developing and evaluating prevention pro-
grammes. Therefore, networks of registries for the surveillance of 
birth defects have been established in different parts of the world. 
In many countries registries are the only source of information, 
enabling the planning of medical treatment and the prevention of 
congenital anomalies (1–4).  
Statistical data in Europe indicate that 2–3% of newborns 
have at least one major congenital anomaly at birth. Congenital 
anomalies are an important cause of foetal, neonatal and child 
mortality and morbidity (1–5), accounting for 25–30% of infant 
deaths in Latvia (6). A birth defect is defined as any abnormal-
ity affecting the structure or function of the body that is present 
from birth (7, 8).
The European Surveillance of Congenital Anomalies (EU-
ROCAT) is a network providing standardized epidemiological 
information on congenital anomalies in Europe. EUROCAT 
member registries collect data from multiple sources on all major 
structural, congenital and chromosomal anomalies (1–3). 
However, it should be mentioned that EUROCAT total 
prevalence rates of congenital anomalies include cases of live 
births, stillbirths, and the terminations of pregnancy for foetal 
anomalies (1).
Epidemiological studies on congenital anomalies are limited 
because they require the analysis of large populations and valid 
data with well-organised and comparable diagnostics. The com-
pleteness of registration and the validity of coding vary by country 
and may also vary by time (1, 4, 9–13). Geographic and socio-
economic differences in the prevalence of congenital anomalies 
have been reported within European and other countries. A vari-
ation in the distributions of risk and protective factors affecting 
total prevalence as well as an additional variation in the prenatal 
detection and termination of pregnancy rates affect the prevalence 
and contribute to the observed variations (1, 4, 9, 12, 14). 
The improvement of mother and child health as well as the 
reduction of infant mortality is one of many goals of the public 
health policy “Public Health Strategy for 2011–2017” in Latvia. 
The general situation regarding the health of mothers and children 
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in Latvia and the main risk factors are described in the Strategy 
(15). It is possible to obtain information on congenital anomalies 
present at birth among newborns in Latvia from three registries: 
the Medical Birth Register (MBR), the National Causes of Death 
Register (NCDR) and the Congenital Anomaly Register (CAR). 
The aim of this study is to examine the contemporary monitoring 
system for congenital anomalies at birth in Latvia and provide the 
prevalence rates with congenital anomalies at birth in the period 
from 2000 until 2010. 
MATERIALS AND METHODS
Source of Data
Retrospective and cross-sectional cohort analyses about the 
period from 2000 to 2010 were performed by obtaining data from 
nationwide, population-based registers that were inter-linked: 
MBR which includes basic information on the prevalence of 
congenital anomalies at birth, NCDR and CAR.
The International Statistical Classification of Diseases and 
Related Health Problems, Tenth Revision (ICD–10), includes birth 
defects in Chapter XVII: Congenital malformations, deformations 
and chromosomal abnormalities with codes (Q00–Q99).
  MBR was established in 1996. Electronic data was available 
since 2000, and it has been based on the information recorded 
in the cards issued for newborns by maternity units across the 
country. All congenital anomalies at birth in this registry were 
diagnosed during the time spent in the maternity unit (usually up 
to the fourth day) by ultrasound examinations and the inspection 
of neonatalogists.
MBR contains information that is essential for epidemiologi-
cal studies and surveys on perinatal health, including data on all 
newborns and their characteristics (for example sex, weight, 
length, gestational age, Apgar score as well as the diagnosis of 
congenital anomalies at birth and the cause of death, wherever ap-
propriate); the mother’s socio-demographic factors (for example 
age, education level, nationality); factors affecting the mother’s 
health (diseases, inimical conditions and health problems during 
pregnancy) and the delivery (the type of delivery, complications). 
MBR is obligatory and covers all national data. 
The information regarding stillbirths and infant deaths up to 
one year of age is available from NCDR, established in 1996. This 
registry is obligatory and covers all deaths cases in the country. 
Autopsies are performed for 99% of foetal deaths and 84% of 
infant deaths to confirm or exclude malformation. The registry 
data include personal information (sex, age, birth weight as well 
as birth and death data), diagnoses of the cause of death, and other 
factors related to death. The information is retrieved from death 
certificates for stillbirths and infant deaths. 
CAR was established in 1994 in accordance with the congeni-
tal anomalies EUROCAT registry requirements. The computer 
programme of the Register, donated by the Dutch EUROCAT 
branches, was identical to the EUROCAT computer programme. 
The register worked more actively in the 1990s, but less actively 
and on voluntary basis during the last ten years. There is complete 
information available on chromosomal abnormalities, such as 
Down’s syndrome. It is connected to the women prenatal screen-
ing for foetal chromosomal abnormalities risk group in the Genet-
ics Centre located in Riga, the capital of Latvia. All the necessary 
examinations (ultrasound screening, biochemical tests etc.) due to 
pregnancy are regulated by the Rules of the Cabinet of Ministers 
No. 611 “Procedures for Assistance with Deliveries” (16).
Since 2008 the Register on Congenital Anomalies has been a 
part of the Register of Patients Suffering from Certain Diseases 
that includes separate registers (such as the Diabetes Register, 
Register of Patients Suffering from Mental Diseases, Alcohol 
Abuse, Trauma Register etc.), which are technically linked into 
one data system.
Statistical Analysis 
A total of congenital anomalies at birth and stillbirth rate with 
congenital anomalies as well as the live birth prevalence rate 
and rate of major congenital anomalies at birth were calculated. 
Terminations of pregnancies due to congenital anomalies were 
not included in the prevalence calculation.
In MBR the diagnoses are classified according to ICD–10. 
These diagnosis codes were correspondingly regrouped in cases 
of major congenital anomalies at birth, adapting the methodology 
of  EUROCAT (17).
Major congenital anomalies were defined as lethal (if the defects 
cause stillbirth; infant death or pregnancies are terminated after 
the prenatal diagnosis) and severe (if the defects without medical 
intervention cause handicap or death) defects altogether (18).
The information from the CAR database was used in the data 
analysis to characterise the registration of congenital anomalies 
at birth and assess the completeness of MBR data. The inter-
comparison of diagnoses was based on 587 records pooled from 
CAR, using the available record linkage with MBR. Also within 
the framework of this analysis, the diagnoses of congenital 
anomalies were grouped in compliance with the EUROCAT major 
congenital anomaly subgroups.
The interrelated comparison of congenital anomaly coverage 
and correspondence of diagnoses within the data analysis (MBR 
vs CAR) was carried out with the help of calculations made ap-
plying the methodology used by Danish researchers (19). The 
coincidence of diagnoses or positive registered cases equals the 
number of newborns correctly diagnosed with congenital anomaly 
at birth in MBR. The coverage of congenital anomaly cases at birth 
or completeness equals the number of newborns with correctly 
diagnosed or unspecified congenital anomaly at birth in MBR. 
This study was approved by the Ethics Committee of Riga 
Stradin’s University on 21 January 2011.
Calculation of Prevalence 
Total prevalence of congenital anomalies at birth: the number 
of live births and stillbirths (stillbirths after 22nd week of preg-
nancy and with birth weight 500 grams) with congenital anomalies 
per 10,000 births.
Live births prevalence of congenital anomalies at birth: the 
number of live births having congenital anomalies per 10,000 
live births. 
Live births prevalence of major congenital anomalies at birth: 
the number of live births having major congenital anomalies 
(according to ICD–10 by EUROCAT methodology) per 10,000 
live births. 
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Stillbirths with congenital anomalies: the number of stillbirths 
(stillbirths after 22nd week of pregnancy and with birth weight 
500 g) having congenital anomalies per 10,000 live births and 
stillbirths.
RESULTS
A total of congenital anomalies at birth prevalence rate was 
323.7 (95% CI 317.5–330.9) per 10,000 live births and stillbirths 
(2000−2010) with the annual decrease of 9.3 cases per 10,000 
live and stillbirths (p < 0.05). 
A total of 7,451 live-born children had at least one congenital 
anomaly at birth (2000–2010) out of which 66.1% (n = 4,927) had 
at least one major congenital anomaly related to serious defects 
for a newborn. These data were obtained from MBR, based on 
the information provided in newborn cards issued by a maternity 
hospital or unit. 
The data on live-born newborns with congenital anomalies at 
birth from MBR gave live birth period prevalence of 319.7 (95% 
CI 286.5–354.0) per 10,000 live births. The live birth prevalence 
with congenital anomalies slightly decreased from the year 2000 
to the year 2010. The average decrease by linear regression was 
8.8 cases per 10,000 live births per year (p > 0.05). The period 
prevalence of major congenital anomalies at birth among live 
births was 211.4/10,000 (95% CI 197.4–226.2). Overall, major 
congenital anomalies prevalence rate has a statistically significant 
decrease – on average by 5.2/10,000 during the years (p < 0.01) 
(Fig. 1.). 
Data on stillbirths can be retrieved from NCDR. From 
2000–2010, there were 1,531 foetal deaths reported, with the 
average of 9.3% (n = 143) stillbirths due to congenital anomalies 
and registered as the main cause of death by NCDR. The still-
birth rate due to congenital anomalies was 6.1 (per 10,000 live 
and stillbirths). 
Table 1 displays the cases and prevalence of live births and 
stillbirths with congenital anomalies at birth from MBR and 
NCDR in Latvia.
The coverage analysis of congenital anomaly registration at 
birth among live births included 587 cases (2000–2010) provided 
by MBR in relation to CAR. It was possible to link both regis-
tration systems as there was 33.2% of information available to 
identify a particular person. 
The coincidence of diagnoses or the number of properly 
registered cases in MBR accounted for 53.8% of cases (95% CI 
49.8–57.8) (Fig. 2.).
The evaluation of completeness of the registered cases in MBR 
in comparison to CAR has showed that it comprises 68.2% of 
cases (95% CI 65.0–72.4). The highest share of diagnosis coin-
cidence and more complete registration at birth institutions is 
related to visual congenital defects, such as cleft lip and cleft palate 
(61.0%; 95% CI 50.2–70.8) as well as limb anomalies (76.6%; 
Year Live birth (n)
Foetal death  
(n)
Live birth 













birth (live and 
stillbirths)**
2000 548 26 414 271.1 204.8 12.8 281.8
2001 707 20 493 360.6 251.5 10.1 368.2
2002 723 13 464 361.6 232.0 6.4 364.9
2003 797 11 516 379.8 245.9 5.2 382.7
2004 767 5 414 376.8 203.4 2.4 376.7
2005 761 14 457 353.3 212.2 6.5 357.6
2006 718 11 492 322.0 220.6 4.9 324.7
2007 747 11 481 320.9 206.6 4.7 323.9
2008 633 12 436 264.1 181.9 5.0 267.4
2009 584 14 413 269.4 190.5 6.4 274.2
2010 466 6 347 243.4 181.2 3.1 245.1
Total 7,451 143 4,927 319.7 211.4 6.1 323.7
n – number, CA – congenital anomalies, 
*per 10,000 live births, **per 10,000 live and stillbirths
Table 1. Cases and prevalence (per 10,000) of congenital anomalies (Q00–Q99) in Latvia (2000–2010) (data sources – Medi-
cal Birth Register and National Causes of Death Register)
Fig. 1. Trends in the live births prevalence of congenital 
anomalies at birth from 2000 to 2010, per 10,000 live births 
(data source – Medical Birth Register).
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95% CI 62.8–86.4). Congenital heart defects (37.5%; 95% CI 
26.7–49.7) have the lowest share in diagnosis coverage in MBR.
DISCUSSION
Our aim is to describe the congenital anomaly monitoring sys-
tem using data from various information sources and to analyse 
the prevalence and stillbirth rates of congenital anomalies at birth. 
The prevalence for the whole time period is calculated for all Q 
diagnosis group (ICD–10; Q00–Q99), as well as the prevalence 
for all major congenital anomalies at birth. The timely (prenatal) 
diagnosis of life threating and other major congenital anomalies 
plays an important role in decision-making process on the termina-
tion of pregnancy done by pregnant women. Moreover, it helps to 
ensure appropriate obstetrical and neonatal care to the condition 
of a foetus and, if necessary, emergency surgical treatment.
Currently, Latvia does not have unified or compatible data-
bases that register congenital anomalies, so there is no reliable 
estimate for the total prevalence of congenital anomalies to apply 
for analyses and comparisons. 
The data of congenital anomaly monitoring system show that in 
Europe the average period (2000–2004) prevalence rate for live-
born comprises 199.3/10,000 (1), whereas the period (2000–2010) 
prevalence rate in Latvia is slightly higher – 211.4 per 10,000 live 
births. The evaluation of a five-year period (2000–2004) shows 
that in Latvia the prevalence of major congenital anomalies among 
newborn, if compared to the EUROCAT average prevalence, is 
even higher – 227.5/10,000. A relatively larger occurrence may be 
explained with more frequent prevalence of congenital anomalies 
among newborns or with overdiagnosing of cases in birth institu-
tions as the diagnoses are not supplemented, validated, or changed 
after the data are sent to MBR. 
The information on congenital anomalies from MBR does not 
include information about cases that are discovered later, after 
the newborns are discharged from the maternity unit. Moreover, 
the diagnoses made in maternity units are not specified later for 
recording in MBR, and there is no feedback from hospitals and 
perinatal care centres. In some cases, there may be over-reporting 
because the diagnosis made in the maternity units is not always 
confirmed by a laboratory.
The analyses of data from MBR have shown that the live birth 
prevalence of total and major congenital anomalies in newborns 
decreased from the year 2000 to 2010. This can partly be explained 
by increased prenatal screening and increasing numbers of termi-
nations of pregnancy due to congenital anomalies. Unfortunately, 
such detailed information on prenatal screening is not available 
in Latvia. However, statistical data show that on average 88% 
of pregnant women of Latvia have an ultrasound examination, 
but prenatally diagnosed cases of anomalies are relatively low. 
For example, in the case of  gastroschisis 76.5% had undergone 
prenatal ultrasound, but only 29.4% of cases were prenatally de-
tected; in the case of  omphalocele 89.3% had undergone prenatal 
ultrasound and 3.6% were prenatally detected (20). According 
to EUROCAT, on average the rates of prenatally diagnosis cases 
are rather high in Europe, e.g. in relation to gastroschisis – 95%; 
spina bifida – 81%; Down’s syndrome – 72% (8).
Furthermore, a new policy and action plan have been intro-
duced in Latvia – “Plan for Improving Mother and Child Heath 
for 2012–2014” that provide changes related to the prenatal diag-
nostics and requires additional medical examinations for pregnant 
women, including ultrasound screening and necessary tests to 
facilitate timely diagnostics of congenital anomalies (16, 21).
A decreasing tendency in the total of prevalence rate of 
congenital anomalies is also observed in WHO and EUROCAT 
data, which is mainly explained by the better antenatal care and 
improved management of known risk factors such as maternal 
chronic health conditions e.g. diabetes, and the reduction of health 
risk behaviours e.g. smoking (1, 22, 23).
The data on congenital anomalies from MBR have not been 
widely used before. Since 2010, MBR can be linked to the Reg-
ister of Patients Suffering from Certain Diseases, also including 
the Register of Congenital Anomalies. This unified information 
system will make the compilation of more reliable data feasible, 
and enable the analysis and comparisons of these data in a much 
broader way. However, different requirements have to be fulfilled 
to improve the completeness, quality and storage of the health 
information system in Latvia. Currently, the improvement and 
restoration of the registry system is ongoing in order to provide 
the necessary records to the system. The e-Health collaboration 
platform pilot project has been designed as the environment for 
an electronic exchange of information between different health 
information systems. In the future, these new data could be avail-
able for public health surveillance and epidemiological studies 
on congenital anomalies, as the linkages of different datasets will 
become feasible. For example, studies of different risk factors, 
trend predictions, evaluations of the quality of health care, and as-
sessment of the burden of disease related to congenital anomalies 
would be possible to improve perinatal and infant health in Latvia.
In Latvia, MBR linkage to CAR and the analysis of the coin-
cidence of diagnoses have showed that on average 53.8% of reg-
istered diagnoses coincide. Thus, CAR contains the information 
on cases that are diagnosed up to one year of age. Similar results 
were achieved by the research carried out in Australia. When the 
information from the Congenial Anomaly Register of Australia 
was compared to the Genetic Centre and Children Hospital Patient 
data, 54% of cases indicated the coincidence of diagnoses (10). 
The assessment of congenital anomalies completeness in MBR 
and its linking with CAR has led to the conclusion that on average 
68.2% of congenital anomalies are discovered in delivery units. 
Fig. 2. Coverage of live born congenital anomalies at birth 
institutions (MBR) in comparison with the Congenital Anomaly 
Register (2000–2010), %.
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The comparison of congenital anomalies coverage in breakdown 
by diagnosis groups has shown that most often maternity units 
register visual congenital defects, whereas the lowest coverage 
is related to congenital heart defects and chromosome anomalies. 
Furthermore, other similar studies on registration coverage have 
reported that most frequently data of the newborn registration 
and birth certificates indicate or notify those congenital defects 
which are more visible (24). 
Nevertheless, it is difficult to assess how many pregnancies 
with congenital anomalies end in spontaneous abortions or 
terminations of pregnancy in Latvia. The lack of information 
significantly affects the indicators of congenital anomalies. 
EUROCAT provides data on the terminations of pregnancies for 
foetal anomalies following prenatal diagnosis (1, 8, 9). As no com-
plete data on the terminations of pregnancy for foetal anomalies 
exist in Latvia, we could not include them in our analysis. The 
data from routine statistics about abortions just indicate a total 
number of medical abortions (25). For instance, there were 293 
medical abortions performed per year with an average decrease 
of 33 abortions (p < 0.01) during the study period (2000–2010). 
Being aware that any registry of congenital anomalies usually 
fulfils several functions: to provide accurate data on the causes 
of congenital anomalies and risk assessment; to track trends and 
identify variations in the occurrence of congenital anomalies at 
birth; to evaluate preventive measures; and to provide evidence 
for maternal health programmes and policy development, one 
should pay attention to other ways of applying the data. Thus, 
these types of routinely collected data provide opportunities for 
research purposes (1, 4, 11–13, 26–28). For example, the Polish 
Registry of Congenital Malformations was established in 1997 
as a local-level registry with a centre at the Poznań University 
of Medical Sciences. Today, this registry is one of the members 
of EUROCAT, providing statistical analyses for a representative 
part of the country. The information maintained in this registry 
has contributed to a decrease in perinatal deaths and the death 
of infants (29). 
So far, congenital anomalies have been identified as one of the 
major groups of mainly rare diseases in need of concerted action 
across Europe. The pooling of expertise, improving of coding and 
classifications, surveillance, evaluation of clusters, and identifica-
tion of possibilities for primary prevention are some of the goals 
of the EU-funded Joint Action EUROCAT 2011–2013, in which 
Latvia is participating as an associated partner. The results of this 
Joint Action are expected to have an important impact on the future 
policy on rare diseases nationally and at the European level (30).
The international data on congenital anomalies vary signifi-
cantly due to the differences in definitions and data availability by 
country. Some countries produce congenital anomaly prevalence 
rates that include live births and stillbirths, some only include live 
births, whereas some also include terminated pregnancies due to 
foetal anomalies following prenatal diagnosis. In the database of 
the World Health Organisation “Health for All” (HFA) the 2010 
rate of congenital anomalies was 2,455 per 100,000 live births 
in Latvia (data source: MBR and NCDR includes live births and 
stillbirths), 3,472/100,000 in Lithuania (Medical Birth Register), 
and 3,968/100,000 in Estonia (annual reporting, maternity hospital 
data (aged 0–6 days). In the Nordic countries the rates of con-
genital anomalies are higher as the data on terminations for birth 
defects and cases which are diagnosed later up to the age of one 
year are included: 3,904/100,000 in Finland (2009) (data source: 
the Register of Congenital Anomalies), 4,681/100,000 in Norway 
(2009) (data source gynaecological/births and paediatric depart-
ments; data includes late-term abortions); and 7,825/100,000 in 
Denmark (2010) (data source: The Birth Registry). The prevalence 
rate of congenital anomalies in Slovakia is on the same level as 
in Latvia – 2,518/100,000 (2010), but is also lower than in the 
Nordic countries (22). The Slovak registry also covers all births 
annually according to the reports of birth defects from delivery 
units (31). In Hungary, that has a higher rate than Latvia or Slova-
kia – 4,730/100,000 (2009), prenatally diagnosed and terminated 
foetuses are registered as well (22). 
These differences may be caused by a variation in the reg-
istration practices and other factors related to data collection 
that should be investigated in greater detail. The comparison 
of the data and monitoring systems of the Nordic and Baltic 
countries would be interesting for researchers and clinicians, 
governments and healthcare workers in the fields of public 
health, epidemiology and health services research. The Nordic 
countries are well-known worldwide for their well-established 
monitoring systems of medical and administrative registers and 
extensive data analysis capabilities related to data linkage. In 
order to ensure the quality of surveillance data, it is important 
to analyse the data to determine the relevance and applicability 
of the obtained information. 
The analysis of different registers related to congenital anoma-
lies has identified several challenges. The primary issue regarding 
multiple data systems is the difficulties in comparing incidences 
by area and time. Therefore, some improvements in the registry 
systems are urgently needed. These improvements should include 
better accuracy and accessibility of registry data, the possibility 
to link registers on congenital anomalies to the causes of death 
and other registries as well as the need to include terminations of 
pregnancy due to congenital anomalies in the surveillance system.
CONCLUSIONS
Several problems encountered in the calculations of congenital 
anomaly prevalence (int. al. total and at birth) show a necessity to 
improve the national registration system of congenital anomalies. 
The present system of congenital anomaly registration should be 
advanced for better completeness. Thus, multiple possibilities for 
inter-linkage would increase the usefulness of accumulated and 
stored information as in research as well as in practical medicine. 
Latvia should use the experience of the Nordic countries and 
introduce a mother’s and children’s identification number (ID) to 
MBR, which would be helpful for a linkage with other registries in 
Latvia, data from hospitals and perinatal centres in order to include 
and validate congenital anomaly diagnoses at birth of newborns 
after their discharge from the maternity unit. Thus, the inclusion 
of terminations of pregnancy due to congenital anomalies in the 
monitoring system is essential.
To perform international comparisons it is highly important 
to establish a common methodology, such as definitions and 
inclusion/exclusion criteria. Right now, this work initiated by 
the EU-funded Joint Action EUROCAT 2011–2013 project has 
already been continued by the Centre for Disease Prevention and 
Control of Latvia together with the Children’s Clinical University 
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Hospital that will facilitate the process of data collection and 
validation on congenital anomalies in the near future. 
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